Sort
34,240 grants matching “atherosclerosis”
Project 3: Plasminogen and Plasminogen Receptors in Inflammation and CVD
$396,251Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P01 · FY2016 · HL
Project 3: Plasminogen and Plasminogen Receptors in Inflammation and CVD
$396,251Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P01 · FY2015 · HL
Project 3: Plasminogen and Plasminogen Receptors in Inflammation and CVD
$396,251Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P01 · FY2017 · HL
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease
$396,250Philip W Shaul · Ut Southwestern Medical Center · R01 · FY2011 · HL
Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis
$396,250Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · HL
Mechanism of atheroprotective function of Akt3 kinase
$396,250Eugene A Podrez · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · HL
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease
$396,250Philip W Shaul · Ut Southwestern Medical Center · R01 · FY2010 · HL
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
$396,250Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles
$396,250Andrei Maiseyeu · Case Western Reserve University · R01 · FY2017 · HL
Specialized lipid mediators and mechanisms of resolution in vascular injury
$396,250Michael Salvatore Conte · University Of California, San Francisco · R01 · FY2016 · HL
Regulation of endothelial cell junctions by VEGF and angiopoietin
$396,250Arie Horowitz · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · HL
Metabolism of the VLDL receptor and ApoE receptor 2
$396,250Joachim J Herz · Ut Southwestern Medical Center · R37 · FY2010 · HL
Probing Cardiovascular Actions of GLP-1 Using Nanoparticles
$396,250Andrei Maiseyeu · Case Western Reserve University · R01 · FY2020 · HL
Role of KLF6 in macrophage lipid homeostasis and atherogenesis
$396,250Ganapati Holanagadde Mahabaleshwar · Case Western Reserve University · R01 · FY2015 · HL
Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis
$396,250Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis
$396,250Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL
Connection of Mineral and Energy Metabolism by the Nuclear Receptor PPAR-gamma
$396,250Yihong Wan · Ut Southwestern Medical Center · R01 · FY2011 · DK
Metabolism of the VLDL receptor and ApoE receptor 2
$396,250Joachim J Herz · Ut Southwestern Medical Center · R37 · FY2011 · HL
Proatherogenic properties of platelet factor 4
$396,250Bruce S Sachais · University Of Pennsylvania · R01 · FY2006 · HL
Mechanism of atheroprotective function of Akt3 kinase
$396,250Eugene A Podrez · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
Role of KLF6 in macrophage lipid homeostasis and atherogenesis
$396,250Ganapati Holanagadde Mahabaleshwar · Case Western Reserve University · R01 · FY2019 · HL
Mechanism of atheroprotective function of Akt3 kinase
$396,250Eugene A Podrez · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · HL
LRP1 and endothelial function
$396,250Xinchun Pi · Baylor College Of Medicine · R01 · FY2017 · HL
Mechanism of atheroprotective function of Akt3 kinase
$396,250Eugene A Podrez · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL
Oxidant resistant apoA1 in reverse cholesterol transport, inflammation and atherosclerosis
$396,250Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL